Skip to main content
. 2020 May 4;38(23):2620–2627. doi: 10.1200/JCO.19.02727

TABLE 2.

Adverse Events (any grade, occurring in ≥ 3% of patients) Suspected to Be Related to Study Treatment

graphic file with name JCO.19.02727t2.jpg